Axsome Therapeutics

Axsome Therapeutics

Yahoo Finance • 7 days ago

13 High-Conviction & Catalyst-Driven Long Ideas for 4Q 2026

Investing.com -- Wells Fargo Securities named 13 stocks across seven sectors as its fourth-quarter 2026 long ideas, citing company-specific catalysts that could drive significant gains. Before you buy NVIDIA: our AI model's stock picks ar... Full story

Yahoo Finance • 22 days ago

Axsome Sees AUVELITY Prescriptions Accelerate as Alzheimer’s Launch Gains Traction

Key Points Interested in Axsome Therapeutics, Inc.? Here are five stocks we like better. AUVELITY prescription growth is accelerating, with weekly new-to-brand prescriptions reaching a record 3,800 and Alzheimer's disease agitation becomi... Full story

Yahoo Finance • 28 days ago

Goldman rebalances its long duration stock basket

[Interest rate percentage sign symbol finance investment graph chart] alexsl The Goldman Sachs equity team has rebalanced its Long Duration Basket amid rising interest rates. Equities usually struggle to digest sharp increases in interes... Full story

Yahoo Finance • 30 days ago

Axsome rises on Auvelity prescription data

[Stock market graphic. Stock price chart.] Andrey Semenov/iStock via Getty Images * Axsome Therapeutics (AXSM [https://seekingalpha.com/symbol/AXSM]) is up ~6% in Friday trading following data showing that prescriptions for Auvelity (de... Full story

Yahoo Finance • 30 days ago

Axsome Therapeutics vs. CRISPR Therapeutics: Which Healthcare Stock Is a Better Buy in 2026?

The healthcare sector is evolving as traditional drug development meets revolutionary gene editing. Investors are now choosing between Axsome Therapeutics (NASDAQ:AXSM) and CRISPR Therapeutics (NASDAQ:CRSP) for their medical portfolios. A... Full story

Yahoo Finance • last month

Axsome Therapeutics vs. Viking Therapeutics: Which Healthcare Stock Is a Better Buy in 2026?

Is it better to own a company already selling drugs or one with a potential blockbuster in testing? Investors are weighing Axsome Therapeutics (NASDAQ:AXSM) against Viking Therapeutics (NASDAQ:VKTX) to decide. Axsome focuses on commercial... Full story

Yahoo Finance • last month

Axsome (AXSM) Down 3.7% Since Last Earnings Report: Can It Rebound?

It has been about a month since the last earnings report for Axsome Therapeutics (AXSM). Shares have lost about 3.7% in that time frame, underperforming the S&P 500. Will the recent negative trend continue leading up to its next earnings... Full story

Yahoo Finance • last month

Axsome Begins Phase III Study on AXS-05 for Smoking Cessation

Axsome Therapeutics AXSM announced that it has dosed the first patient in the phase III SUMMIT study evaluating AXS-05 for the treatment of smoking cessation. The randomized, double-blind, placebo-controlled phase III SUMMIT study is desi... Full story

Yahoo Finance • last month

Amgen vs. Axsome Therapeutics: Which Healthcare Stock Is a Better Buy in 2026?

Choosing between Amgen (NASDAQ:AMGN) and Axsome Therapeutics (NASDAQ:AXSM) means weighing the established stability of a global pharmaceutical leader against the rapid growth of an emerging central nervous system specialist. Amgen operate... Full story

Yahoo Finance • 2 months ago

Axsome Therapeutics Stock Is Up 16% Year to Date. Why Wall Street Thinks It Has Even More Room to Run

Axsome Therapeutics (NASDAQ: AXSM), a biotech company, has performed fairly well this year. The company's shares are up 16% versus the S&P 500's 11%. Could the stock rise even higher? Wall Street certainly thinks so. Axsome Therapeutics' a... Full story

Yahoo Finance • 2 months ago

Axsome signals 1 NDA per year through 2030 as AXS-12 targets May 1, 2027 PDUFA

Earnings Call Insights: Axsome Therapeutics (AXSM) Q2 2026 MANAGEMENT VIEW * "The second quarter was highly productive for Axsome as we grew our commercial business robustly and made important regulatory and clinical progress across ou... Full story

Yahoo Finance • 2 months ago

Here are the major earnings before the open Monday

Major earnings expected before the bell on Monday include: * Barrick Mining Corporation (B [https://seekingalpha.com/symbol/B]) * Medical Properties Trust (MPT [https://seekingalpha.com/symbol/MPT]) * Seadrill Limited (SDRL [https:/... Full story

Yahoo Finance • 2 months ago

The Next Billion-Dollar Opportunity in Alzheimer's Disease Market: 6 Pipeline Therapies to Watch | DelveInsight

The Alzheimer's disease market dynamics are anticipated to change due to the expected launch of emerging therapies, such as Masupirdinea (Suven Life Sciences), Trontinemabb (Roche), Buntanetap (Annovis bio), Masitinib (AB Science), Remtern... Full story

Yahoo Finance • 3 months ago

Axsome Therapeutics (AXSM) Stock is Attractive on the Back of its Key Drug

ClearBridge Investments, a global equity manager, recently published second-quarter 2026 commentary for its "Small Cap Growth Strategy". A copy of the letter can be downloaded here. The Russell 2000 Growth Index increased by 25.6% in the s... Full story

Yahoo Finance • 3 months ago

William Blair updates conviction list: Oracle in, Meta out and more

[Technology background image, graph, displaying analytical data about stock trading.] Donny DBM William Blair added Oracle (ORCL [https://seekingalpha.com/symbol/ORCL]), American Express (AXP [https://seekingalpha.com/symbol/AXP]), Ecolab... Full story

Yahoo Finance • 4 months ago

Axsome Therapeutics Announces Settlement Resolving All SUNOSI® (solriamfetol) Patent Litigation

Axsome Therapeutics, Inc. NEW YORK, June 03, 2026 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM) (Axsome), a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders, today annou... Full story

Yahoo Finance • 5 months ago

3 Overlooked Stocks Set to Soar in 2026

Smaller biotech stocks often fly under the radar. Many of them aren't consistently profitable, but some can deliver outsize growth for investors. Axsome Therapeutics(NASDAQ: AXSM) is a mid-cap with only three approved therapies, while sma... Full story

Yahoo Finance • 5 months ago

Stocks making the biggest moves midday: Berkshire, AMD, Circle, FedEx, UPS & more

Check out the companies making the biggest moves in midday trading. Logistics firms — Shares of logistics companies were under pressure after Amazon said it would launch Amazon Supply Chain Services , its own freight, distribution, fulfill... Full story

Yahoo Finance • 5 months ago

Axsome (AXSM) Q2 2025 Earnings Transcript

Image source: The Motley Fool. DATE Monday, Aug. 4, 2025 at 8 a.m. ET CALL PARTICIPANTS Chief Executive Officer — Herriot Tabuteau Chief Financial Officer — Nick Pizzie Chief Commercial Officer — Ari Maizel Chief Operating Officer — Ma... Full story

Yahoo Finance • 5 months ago

Axsome (AXSM) Q1 2025 Earnings Call Transcript

Image source: The Motley Fool. DATE Monday, May 5, 2025 at 8:00 a.m. ET CALL PARTICIPANTS Chief Executive Officer — Dr. Herriot Tabuteau Chief Financial Officer — Nick Pizzie Chief Commercial Officer — Ari Maizel Chief Operating Office... Full story